Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Biochemistry|December 17, 2003
Solution structure of human saposin C: pH-dependent interaction with phospholipid vesiclesEva de Alba, Solly Weiler, Nico TjandraCancer Cell|September 21, 2002
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeuticsAnthony Letai, Michael C Bassik, Loren D Walensky, et al.Developmental Cell|January 10, 2002
A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosisLuca Scorrano, Mona Ashiya, Karolyn Buttle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2014
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor modelsKristan Meetze, Sylvie Vincent, Steven Tyler, et al.Molecular Cancer Therapeutics|May 22, 2015
23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal ToxicityTheresa Proia, Feng Jiang, Alisa Bell, et al.Cancer Research|August 17, 2010
GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signalingAilin Bai, Kristan Meetze, Nhi Y Vo, et al.Journal of Cachexia, Sarcopenia and Muscle|May 31, 2016
MAP3K11/GDF15 axis is a critical driver of cancer cachexiaLorena Lerner, Julie Tao, Qing Liu, et al.Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Prodrug thiamine analogs as inhibitors of the enzyme transketolaseYvan Le Huerou, Indrani Gunawardana, Allen A Thomas, et al.Nature Communications|May 9, 2019
Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor responsePatrick A Baeuerle, Jian Ding, Ekta Patel, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Non-charged thiamine analogs as inhibitors of enzyme transketolaseAllen A Thomas, J De Meese, Y Le Huerou, et al.Pageof 2